Delivery Order SPE2DR25D3201-SPE2DR26FT5VG
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,296.38 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Entecavir is an antiviral medication primarily used in the treatment of chronic hepatitis B, representing a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count package) with a ceiling value of $1,335.97. The contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.05 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) on January 20, 2026, with completion scheduled for January 21, 2026. This competitive award, made without set-aside designation, represents a firm fixed-price purchase of pharmaceutical inventory to support federal medical supply needs. The product will be delivered to the contracting entity's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $15,850.71 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) on a firm fixed price basis. The order, with a completion deadline of November 6, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,866.48 to AmerisourceBergen Drug Corp for 30 tablets of Entecavir 0.5 mg, an antiviral medication commonly used to treat chronic hepatitis B. The contract, which is not set-aside, was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizing firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Entecavir 0.5 mg, an antiviral medication commonly used in hepatitis B treatment. This competitively awarded, firm fixed-price delivery order has a ceiling value of $8,176.47 and an ultimate completion date of October 30, 2025. The contract carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,202.28 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $5,583.57 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,062.15 contract is for the delivery of Entecavir 0.5 milligram tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Entecavir 0.5 mg, an antiviral medication used in hepatitis B treatment, with a contract ceiling value of $8,002.96. This competitively awarded, firm fixed-price delivery order was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside...